SEKISUI CHEMICAL CO., LTD. (President and Representative Director: Ikusuke Shimizu; hereafter, “SEKISUI CHEMICAL”) hereby announces that it has launched Ceglu™ cultureware, culture plates pre-coated with Ceglu™, a cell-adhesive polymer (chemically-defined scaffolds material) for stable stem cell culture and other applications including iPS cells, in North America in February 2026. Sales in Japan commenced in June 2025, by expanding into regions where research and development in regenerative medicine, drug development, and cell therapy are thriving, SEKISUI CHEMICAL will contribute to accelerating the practical application of regenerative medicine.

1. Background

  Although modern medicine continues to make steady progress, many health challenges remain, including rare diseases, age-related diseases, and physical injury. Regenerative medicine, particularly therapies using iPS cells, holds the potential to address these challenges. Since iPS cells can be generated from a patient’s or healthy own cells, and have the ability to differentiate into various cells. However, cell-adhesive coating materials are essential for iPS cell culture, and conventional protein-derived coating materials have faced issues in terms of uniformity and stability, becoming a major barrier to the industrial expansion and practical application of regenerative medicine. Ceglu™ is a new polymer product developed to address these challenges, and from the outset, SEKISUI CHEMICAL has been advancing its business development with global expansion in mind.

2. Expansion in North America

  North America is one of the regions where research and development in regenerative medicine, drug development, and cell therapy are thriving and represents the world’s largest cell culture market. By enabling a wide range of researchers and companies in this region to use Ceglu™ cultureware, SEKISUI CHEMICAL aims to help accelerate the practical application of regenerative medicine. SEKISUI CHEMICAL has established a marketing base in San Diego, California, and has been actively engaged in activities aimed at expanding into North America. By providing samples to cell manufacturing institutions and university researchers, strong demand for Ceglu™ has been confirmed. Through the sales of this product, SEKISUI CHEMICAL will contribute to the further development of regenerative medicine in North America.

• （Sales area）
      United States, Canada
  
  （Product lineup）
      Ceglu™ cultureware
      ・Ceglu™ multiwell plate (6-well)
      ・Ceglu™ multiwell plate (96-well)
      ・Ceglu™ dish (100mm)
  
• 
  Ceglu™cultureware
  

3. About Ceglu™

  Ceglu™ is a chemically synthesized polymer that enables the culture of iPS cells and can be solubilized to coat the surfaces of various materials. Compared to proteins, it has high stability at room temperature and does not require a cold chain.* In addition, it does not contain any animal-derived ingredients in its production process and offers high safety.
  SEKISUI CHEMICAL provides Ceglu™ coating solution, a coating agent, and Ceglu™ cultureware, pre-coated plates, and aims to establish a consistent cell-adhesion platform from laboratory scale to manufacturing scale. Examples of its application to date include differentiation into iPS cell-derived cardiomyocytes, improved reproducibility of cell quality through combination with automated culture equipment, and scale-up of cell culture through coating of nonwoven fabrics and microcarriers.
Ceglu™ Website： https://www.sekisui-cell.jp/en/products/ceglu/

*Cold chain: A logistics method that keeps fresh food, pharmaceuticals, etc. at low temperatures without interruption throughout the production, transportation, and consumption process.